APA

Antolín S., Mel R., Ramos M., García-Palomo A., Almanza C., de Paz L., Calvo L., Alvarez E., González A. & García-Mata J. (20120104). A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Chicago

Antolín Silvia, Mel Ramón, Ramos Manuel, García-Palomo Andrés, Almanza Concepción, de Paz Laura, Calvo Lourdes, Alvarez Elena, González Ana and García-Mata Jesús. 20120104. A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Harvard

Antolín S., Mel R., Ramos M., García-Palomo A., Almanza C., de Paz L., Calvo L., Alvarez E., González A. and García-Mata J. (20120104). A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

MLA

Antolín Silvia, Mel Ramón, Ramos Manuel, García-Palomo Andrés, Almanza Concepción, de Paz Laura, Calvo Lourdes, Alvarez Elena, González Ana and García-Mata Jesús. A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20120104.